ICD-10-CM Billable Code

C50.61

Malignant neoplasm of axillary tail of breast, female

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the axillary tail of the breast, coded as C50.61 in ICD-10, refers to a type of breast cancer that develops in the axillary tail—a small extension of breast tissue in the armpit area. This condition primarily affects women and requires prompt medical attention for diagnosis and treatment. Recognizing the features and potential implications of this diagnosis can help in understanding the importance of specific medical interventions.

Causes & Symptoms

Clinical Causes: Genetic factors that predispose individuals to breast cancer Family history of breast cancer or other related cancers Hormonal influences such as prolonged exposure to estrogen Lifestyle factors including alcohol consumption, smoking, and lack of physical activity Environmental exposures to carcinogens Previous breast tissue damage or radiation therapy in the chest area

Key Symptoms: Lump or mass in the axillary region or upper outer quadrant of the breast Swelling or a noticeable enlarging of the breast tissue Pain or tenderness in the affected area Changes in the skin over the breast or armpit, such as redness or dimpling Nipple changes, including inversion or discharge Unexplained weight loss or fatigue in advanced cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing malignant neoplasm of the axillary tail involves several steps to confirm the presence and extent of the cancer: - Clinical examination focusing on the breast and armpit areas - Imaging studies such as mammography and ultrasound to visualize the tumor - Biopsy procedures, including needle biopsy or excisional biopsy, to obtain tissue samples for histopathological analysis - Additional imaging like MRI or CT scans to determine the spread of the disease - Blood tests to assess overall health and rule out other conditions Early detection through regular screening and prompt investigation of symptoms are vital components of managing this condition effectively.

Treatment Protocols: Treatment strategies for malignant neoplasm of the axillary tail are tailored to each patient's specific situation, including tumor size, stage, and overall health: - Surgery, typically involving removal of the tumor, may include lumpectomy or mastectomy, often combined with removal of affected lymph nodes - Radiation therapy to target residual cancer cells in the breast or armpit - Chemotherapy to address cancer cells that may have spread beyond the primary site - Hormonal therapy for hormone receptor-positive tumors to block cancer growth - Targeted therapy, which uses drugs designed to attack specific molecules involved in cancer progression - Regular follow-up examinations and imaging to monitor for recurrence or metastasis Multidisciplinary care involving oncologists, surgeons, radiologists, and support teams is essential for optimal outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.61 a billable ICD-10 code?
Yes, C50.61 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.61?
Clinical documentation must specify the nature of Malignant neoplasm of axillary tail of breast, female and any associated comorbidities for accurate reporting.

Cite this Clinical Reference